Table 1. Serum labs pre- and post-elotuzumab infusion.
| Serum parameter (units) | Pre-elotuzumab (November 15, 2016) | Post-elotuzumab (November 22, 2016) |
|---|---|---|
| Sodium (mmol/L) | 137 | 133 |
| Potassium (mmol/L) | 4.5 | 6.2 |
| Chloride (mmol/L) | 102 | 93 |
| CO2 (mmol/L) | 27 | 23 |
| Urea nitrogen (mg/dL) | 18 | 93 |
| Creatinine (mg/dL) | 1.26 | 9.51 |
| Glucose (mg/dL) | 134 | 104 |
| Calcium (mg/dL) | 9.9 | 9.7 |
| Protein (g/L) | 8.5 | 8.8 |
| Albumin (g/L) | 3.2 | 3.2 |
| AST (IU/L) | 71 | 68 |
| ALT (IU/L) | 15 | 43 |
| Alkaline phosphatase (IU/L) | 123 | 326 |
| Total bilirubin (mg/dL) | 0.7 | 1.4 |
| Phosphorus (mg/dL) | Not checked | 4.9 |
| Uric acid (mg/dL) | Not checked | 35.9 |
| Lactate dehydrogenase (IU/L) | Not checked | 606 |
| Lactate (mmol/L) | Not checked | 0.8 |
| White blood cells (K/µL) | 5.8 | 4.0 |
| Hemoglobin (g/dL) | 9.9 | 7.7 |
| Platelets (K/µL) | 83 | 30 |
| Plasmacytes (% of CBC differential) | 4.0 | 7.0 |
| Haptoglobin (mg/dL) | Not checked | 251 |
| INR | Not checked | 5.7 |
| PTT (sec) | Not checked | 58 |
| Fibrinogen (mg/dL) | Not checked | 345 |
| Dabigatran (µg/mL) | Not checked | > 1.0 |
AST = aspartate aminotransferase; ALT = alanine aminotransferase; PTT = partial thromboplastin time.